Increased cardiotoxicity of sorafenib in sunitinib-pretreated patients with metastatic renal cell carcinoma [3]

Annals of Oncology

Volumn 18, Issue 11, 2007, Pages 1906-1907

  Mego, Miso ^a   Reckova, M ^a   Obertova, J ^a   Sycova Mila, Z ^a   Brozmanova, K ^a   Mardiak, J ^a  

^a Physics and Informatics   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; FLUOROURACIL; INTERFERON; INTERLEUKIN 2; PAZOPANIB; SORAFENIB; SUNITINIB;

ADULT; CARDIOTOXICITY; CASE REPORT; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FATIGUE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCALCEMIA; KIDNEY CARCINOMA; LETTER; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; MOUTH PAIN; PLEURA EFFUSION; PRIORITY JOURNAL; SIDE EFFECT; SURGICAL DRAINAGE; THORAX PAIN;

AGED; ATRIAL FIBRILLATION; BENZENESULFONATES; CARCINOMA, RENAL CELL; CARDIOVASCULAR DISEASES; CHEST PAIN; DRUG INTERACTIONS; FOLLOW-UP STUDIES; HUMANS; INDOLES; KIDNEY NEOPLASMS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PYRIDINES; PYRROLES; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 36148975365     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm489     Document Type: Letter

References (5)

1. Motzer RJ, Bukowski RM. Targeted therapy for metastatic renal cell carcinoma. J Clin Oncol 2006; 24: 5601-5608.
2. Sablin MP, Bouaita L, Balleyguier C et al. Sequential use of sorafenib and sunitinib in renal cancer: Retrospective analysis in 90 patients. J Clin Oncol 2007; 25 (18 Suppl).
3. Motzer RJ, Bacik J, Murphy BA et al. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol 2002; 20: 289-296.
4. Bayer Pharmaceuticals. Nexavar (sorafenib) Prescribing Information. 2006 http://www.univgraph.com/bayer/inserts/nexavar.pdf.
5. Force T, Krause DS, Van Etten RA. Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition. Nat Rev Cancer 2007; 7: 332-344.